Role of nanotechnology in mastitis treatment for dairy cows: a mini review

Nanotechnology in mastitis treatment

Authors

  • Ved Prakash Department of Animal Husbandry and Dairying, Chandra Shekhar Azad University of Agriculture and Technology, Kanpur - 208002, Uttar Pradesh India
  • Aman Rathaur Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi - 221005, Uttar Pradesh India
  • Dinesh Chandra Rai Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi - 221005, Uttar Pradesh India
  • Samar Jeet Singh Department of Animal Husbandry and Dairying, Chandra Shekhar Azad University of Agriculture and Technology, Kanpur - 208002, Uttar Pradesh India

DOI:

https://doi.org/10.62310/liab.v2i2.95

Keywords:

Antibiotics, Mastitis, Nanoparticles, Nanotechnology, Pathogens

Abstract

Mastitis is among the most popular ailments in dairy cow that results in the greatest financial losses for dairy farms. Different strains of bacteria, fungus, and algae are responsible for causing mastitis. Mostly this disease is typically caused by bacteria that grow in the udder and lymph nodes, causing damage to the udder parenchyma. Antibiotics are the primary method of treatment for mastitis. However, long-term use of antibiotics has caused pathogens that cause mastitis to become more resistant to antibiotics. As a result, various strategies for eliminating pathogenic bacteria that cause mastitis are being researched. Researchers have looked for alternative therapeutic modalities to antibiotics for the treatment of mastitis. These efforts are helped by the innovative invention of nanotechnology for mastitis therapy and management. As a result, nanotechnology may become the primary type of mastitis treatment in the near future. In vitro-In vivo research of alternative remedy for mastitis have indicated that many microorganisms responsible for this disease can be successfully inhibited and destroyed. The current review article discusses different nanoparticles for mastitis treatment in dairy cow herds.

Metrics

Metrics Loading ...

References

Algharib SA, Dawood A, Xie S. (2020). Nanoparticles for treatment of bovine Staphylococcus aureus mastitis. Drug Delivery 27(1): 292-308.

Ali HR, Emam AN, Hefny EG, Koraney NF, Mansour AS, Salama AM, Ali SF, Aboolo SH, Shahein MA. (2021). Silver nanoparticles enhance the effectiveness of traditional antibiotics against S. aureus causing bovine mastitis within the safety limit. Journal of Nanoparticle Research 23(11): 1-18.

Angele-Martinez C, Nguyen KVT, Ameer FS, Anker JN, Brumaghim JL. (2017). Reactive oxygen species generation by copper (II) oxide nanoparticles determined by DNA damage assays and EPR spectroscopy. Nanotoxicology 11(2): 278-288.

Argaw A. (2016). Review on epidemiology of clinical and subclinical mastitis on dairy cows. Food Science and Quality Management 52(6): 56-65.

Ashraf A, Imran M. (2020). Causes, types, etiological agents, prevalence, diagnosis, treatment, prevention, effects on human health and future aspects of bovine mastitis. Animal Health Research Reviews 21(1): 36-49.

Beyene Z, Ghosh R. (2021). The possibility of using zinc oxide nano particles for treatment of bovine-subclinical mastitis, In Vitro antibacterial activity. Global Journal of Biology, Agriculture, and Health Sciences 10(4):1000110.

Bhat AM, Soodan JS, Tikoo A. (2016). Study on prevalence of sub-clinical mastitis in crossbred dairy cattle and its potential risk factors. Journal of Animal Research 6(4): 747-749.

Castelani L, Arcaro JRP, Braga JEP, Bosso AS, Moura Q, Esposito F, Sauter IP, Cortez M, Lincopan N. (2019). Short communication: Activity of nisin, lipid bilayer fragments and cationic nisin-lipid nanoparticles against multi-drug resistant Staphylococcus spp. isolated from bovine mastitis. Journal of Dairy Science 102(1): 678–683.

Cheng WN, Han SG. (2020). Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments-A review. Asian-Australasian journal of animal sciences 33(11): 1699-1713.

Cobirka M, Tancin V, Slama P. (2020). Epidemiology and classification of mastitis. Animals 10(12): 2212.

Dakal TC, Kumar A, Majumdar RS, Yadav V. (2016). Mechanistic basis of antimicrobial actions of silver nanoparticles. Frontiers in Microbiology 7: 1831.

De Barros M, Perciano PG, Dos Santos MH, De Oliveira LL, Costa ED, Moreira MAS. (2017). Antibacterial activity of 7-Epiclusianone and its novel copper metal complex on Streptococcus spp. isolated from bovine mastitis and their cytotoxicity in MAC-T Cells. Molecules (Basel, Switzerland) 22(5): 823.

Dehkordi SH, Hosseinpour F, Kahrizangi AE. (2011). An in vitro evaluation of antibacterial effect of silver nanoparticles on Staphylococcus aureus isolated from bovine subclinical mastitis. African Journal of Biotechnology 10(52): 10795-10797.

Drackley JK. (1999). Biology of dairy cows during the transition period: The final frontier?. Journal of Dairy Science 82(11): 2259-2273.

Driskell JD, Tripp RA. (2009). Emerging technologies in nanotechnology-based pathogen detection. Clinical Microbiology Newsletter 31(18): 137-144.

Gomes F, Henriques M. (2016). Control of bovine mastitis: old and recent therapeutic approaches. Current Microbiology 72(4): 377–382.

Hogeveen H, Steeneveld W, Wolf CA. (2019). Production diseases reduce the efficiency of dairy production: A review of the results, methods, and approaches regarding the economics of mastitis. Annual Review of Resource Economics 11: 289-312.

Hussain R, Javed MT, Khan A. (2012). Changes in some biochemical parameters and somatic cell counts in the milk of buffalo and cattle suffering from mastitis. Pakistan Veterinary Journal 32(3): 418-421.

Ingle AP, Duran N, Rai M. (2014). Bioactivity, mechanism of action, and cytotoxicity of copper-based nanoparticles: a review. Applied Microbiology and Biotechnology 98(3): 1001-1009.

Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. (2009). Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Molecular Pharmaceutics 6(5): 1388-1401.

Kalinska A, Jaworski S, Wierzbicki M, Gołębiewski M. (2019). Silver and copper nanoparticles—an alternative in future mastitis treatment and prevention? International Journal of Molecular Sciences 20(7): 1672.

Kalinska A, Wojcik A, Slosarz J, Kruzinska B, Michalczuk M, Jaworski, S, Wierzbicki M, Gołębiewski M. (2018). Occurrence and aetiology of Staphylococcal mastitis-a review. Animal Science Papers & Reports 36(3): 263-273.

Kibebew K. (2017). Bovine mastitis: A review of causes and epidemiological point of view. Journal of Biology, Agriculture and Healthcare 7(2): 1-14.

Krishnamoorthy P, Goudar AL, Suresh KP, Roy P. (2021). Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis. Research in Veterinary Science 136: 561-586.

Kruk T, Szczepanowicz K, Stefanska, J, Socha RP, Warszynski P. (2015). Synthesis and antimicrobial activity of monodisperse copper nanoparticles. Colloids and surfaces. B, Biointerfaces 128: 17–22.

Lakew BT, Fayera T, Ali YM. (2019). Risk factors for bovine mastitis with the isolation and identification of Streptococcus agalactiae from farms in and around Haramaya district, eastern Ethiopia. Tropical Animal Health and Production 51(6): 1507-1513.

Lange A, Grzenia A, Wierzbicki M, Strojny-Cieslak B, Kalinska A, Gołębiewski M, Radzikowski D, Sawosz E, Jaworski S. (2021). Silver and copper nanoparticles inhibit biofilm formation by mastitis pathogens. Animals 11(7): 1884.

Martins SA, Martins VC, Cardoso FA, Germano J, Rodrigues M, Duarte C, Bexiga R, Cardoso S, Freitas PP. (2019). Biosensors for on-farm diagnosis of mastitis. Frontiers in Bioengineering and Biotechnology 7: 186.

Mikhailova EO. (2021). Gold nanoparticles: Biosynthesis and potential of biomedical application. Journal of Functional Biomaterials 12(4): 70.

Neculai-Valeanu AS, Ariton AM, Madescu BM, Rimbu CM, Creanga Ş. (2021). Nanomaterials and essential oils as candidates for developing novel treatment options for bovine mastitis. Animals 11(6): 1625.

Nitz J, Wente N, Zhang Y, Klocke D, Tho Seeth M, Kromker V. (2021). Dry Period or Early Lactation – Time of onset and associated risk factors for intra-mammary infections in dairy cows. Pathogens 10(2): 224.

Omara ST. (2017). MIC and MBC of honey and gold nanoparticles against methicillin-resistant (MRSA) and vancomycin-resistant (VRSA) coagulase-positive S. aureus isolated from contagious bovine clinical mastitis. Journal of Genetic Engineering and Biotechnology 15(1): 219-230.

Orellano MS, Isaac P, Breser ML, Bohl LP, Conesa A, Falcone RD, Porporatto C. (2019). Chitosan nanoparticles enhance the antibacterial activity of the native polymer against bovine mastitis pathogens. Carbohydrate Polymers 213: 1–9.

Pal M, Regasa A, Gizaw F. (2019). Etiology, pathogenesis, risk factors, diagnosis and management of bovine mastitis: A comprehensive review. International Journal of Animal and Veterinary Sciences 6: 40-55.

Pascu C, Herman V, Iancu I, Costinar L. (2022). Etiology of mastitis and antimicrobial resistance in dairy cattle farms in the western part of Romania. Antibiotics 11(1): 57.

Persson Waller K, Persson Y, Nyman AK, Stengarde L. (2014). Udder health in beef cows and its association with calf growth. Acta Veterinaria Scandinavica 56(1): 1-8.

Pramanik A, Laha D, Bhattacharya D, Pramanik P, Karmakar P. (2012). A novel study of antibacterial activity of copper iodide nanoparticle mediated by DNA and membrane damage. Colloids and Surfaces B: Biointerfaces 96: 50-55.

Rathaur A, Prakash V, Yamini S, Yadav SP, Singh SJ. (2020). Effect of low cost herbal combination and tri-sodium citrate treatment in subclinical mastitis affected crossbred dairy cow. Pharma Innovation Journal 9(5): 132-135.

Ren G, Hu D, Cheng EW, Vargas-Reus MA, Reip P, Allaker RP. (2009). Characterization of copper oxide nanoparticles for antimicrobial applications. International Journal of Antimicrobial Agents 33(6): 587-590.

Sanchez-Lopez E, Gomes D, Esteruelas G, Bonilla L, Lopez-Machado AL, Galindo R, Cano A, Espina M, Ettcheto M, Camins A, Silva AM, Durazzo A, Santini A, Garcia ML, Souto, EB. (2020). Metal-based nanoparticles as antimicrobial agents: an overview. Nanomaterials 10(2): 292.

Santhoshkumar P, Prasanna K, Jo YN, Sivagami IN, Kang SH, Lee, CW. (2019). Hierarchically structured mesoporous bimetallic oxides as a potential anode material for rechargeable lithium batteries. Journal of Alloys and Compounds 771: 555-564.

Shaheen M, Tantary HA, Nabi SU. (2016). A treatise on bovine mastitis: disease and disease economics, etiological basis, risk factors, impact on human health, therapeutic management, prevention and control strategy. Advances in Dairy Research 4:1-10.

Shamaila S, Zafar N, Riaz S, Sharif R, Nazir J, Naseem S. (2016). Gold nanoparticles: an efficient antimicrobial agent against enteric bacterial human pathogen. Nanomaterials 6(4): 71.

Shamila-Syuhada AK, Rusul G, Wan-Nadiah WA and Chuah LO (2016). Prevalence and antibiotics resistance of Staphylococcus aureus isolates isolated from raw milk obtained from small-scale dairy farms in Penang, Malaysia. Pakistan Veterinary Journal 36: 98–102.

Sharma N, Singh SG, Sharma S, Gupta SK, Hussain K. (2018). Mastitis occurrence pattern in dairy cows and importance of related risk factors in the occurrence of mastitis. Journal of Animal Research 8(2): 315-326.

Singh M, Sharma A, Mittal D, Yadav P, Charaya G. (2016). Assessment of lactate dehydrogenase enzyme activity in milk as a marker for detection of subclinical mastitis. Journal of Animal Research 6(2): 113-116.

Stevens M, Piepers S, De Vliegher S. (2016). Mastitis prevention and control practices and mastitis treatment strategies associated with the consumption of (critically important) antimicrobials on dairy herds in Flanders, Belgium. Journal of Dairy Science 99(4): 2896-2903.

Umadevi M, Rani T, Balakrishnan T, Ramanibai R. (2011). Antimicrobial activity of silver nanoparticles prepared under an ultrasonic field. International Journal of Pharmaceutical Sciences and Nanotechnology 4(3): 1491-1496.

Wang S, Lawson R, Ray PC, Yu H. (2011). Toxic effects of gold nanoparticles on Salmonella typhimurium bacteria. Toxicology and Industrial Health 27(6): 547-554.

Wani IA, Ahmad T. (2013). Size and shape dependent antifungal activity of gold nanoparticles: a case study of Candida. Colloids and surfaces B: Biointerfaces 101: 162-170.

Wernicki A, Puchalski A, Urban-Chmiel, R, Dec M, Stegierska D, Dudzic A, Wojcik A. (2014). Antimicrobial properties of gold, silver, copper and platinum nanoparticles against selected microorganisms isolated from cases of mastitis in cattle. Medycyna Weterynaryjna 70(9): 564-567.

Williamson J, Callaway T, Rollin E, Ryman V. (2022). Association of milk somatic cell count with bacteriological cure of intra-mammary infection – A Review. Agriculture 12(9): 1437.

Xu L, Wang YY, Huang J, Chen CY, Wang ZX, Xie H. (2020). Silver nanoparticles: Synthesis, medical applications and biosafety. Theranostics 10(20): 8996.

Yu L, Shang F, Chen X, Ni J, Yu L, Zhang M, Sun D, Xue T. (2018). The anti-biofilm effect of silver-nanoparticle-decorated quercetin nanoparticles on a multi-drug resistant Escherichia coli strain isolated from a dairy cow with mastitis. Peer J 6: e5711.

Zain NM, Stapley AGF, Shama G. (2014). Green synthesis of silver and copper nanoparticles using ascorbic acid and chitosan for antimicrobial applications. Carbohydrate Polymers 112: 195-202.

Downloads

Published

07-01-2023

How to Cite

Prakash, V., Rathaur, A., Rai, D. C., & Singh, S. J. (2023). Role of nanotechnology in mastitis treatment for dairy cows: a mini review: Nanotechnology in mastitis treatment. Letters In Animal Biology, 2(2), 29–34. https://doi.org/10.62310/liab.v2i2.95

Issue

Section

Review Articles
Recieved 2022-12-06
Accepted 2023-01-05
Published 2023-01-07